This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)
C3_RECTOSIGMOID_JUNCTION_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
1029 |
4. Check minimum number of eventsNone |
1029 |
5. Include endpointsNone |
1029 |
6. Filter based on genotype QC (FinnGen only) |
1029 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Colorectal cancer, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1029 | 397 | 632 |
| Unadjusted period prevalence (%) | 0.22 | 0.14 | 0.28 |
| Median age at first event (years) | 68.30 | 65.92 | 69.80 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 497
- Matched controls
- 4968
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
323.3
274
*
8140/3-C19.9
ICD-O-3
Adenocarcinoma, NOS, of rectosigmoid junction
+∞
323.0
423
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
253.5
221
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
247.1
216
*
L01BC06
ATC
capecitabine; oral
+∞
239.5
210
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
201.1
179
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
162.7
147
*
A04AA02
ATC
granisetron; systemic, transdermal
1959.1
153.5
141
*
A03FA01
ATC
metoclopramide; systemic, rectal
19.8
152.3
255
251
H02AB02
ATC
dexamethasone; systemic
128.0
146.1
152
17
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
22.0
136.6
213
164
UJF32
NOMESCO Finland
Coloscopy
10.9
126.2
338
813
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
117.4
108
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
49.8
114.5
138
38
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
106.1
98
*
JN4BD
NOMESCO Finland
Extensive body CT
21.8
102.4
156
102
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
86.0
80
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
80.4
75
*
B01AB05
ATC
enoxaparin; parenteral
5.7
68.5
273
875
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
383.4
67.2
66
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
369.6
65.1
64
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
65.0
61
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
37.9
62.8
80
25
JN4AD
NOMESCO Finland
Body CT examination
16.2
58.8
98
74
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
55.2
52
*
JFB47
NOMESCO Finland
Laparoscopic resection of sigmoid colon
107.0
53.1
57
6
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
12.5
52.7
99
97
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
283.3
51.1
51
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
50.9
48
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
50.9
48
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.8
49.8
211
661
TPH07
NOMESCO Finland
Cathetrisation of artery
7.1
49.6
134
244
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
48.7
46
*
JG1BG
NOMESCO Finland
MRI of rectum
514.7
48.2
47
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
47.7
45
*
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
+∞
47.7
45
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
45.5
43
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
44.4
42
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.1
44.0
87
93
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
43.4
41
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
42.3
40
*
JFF23
NOMESCO Finland
Transversostomy
98.8
41.5
45
5
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
+∞
41.2
39
*
Z51.5
ICD-10 Finland
Palliative care
17.7
40.4
64
41
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
40.1
38
*
D75
ICPC
Malignant neoplasm colon/rectum
+∞
40.1
38
*
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
418.8
39.6
39
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
148.5
39.4
41
*
B01AB10
ATC
tinzaparin; parenteral
11.4
38.3
74
75
WZC30
NOMESCO Finland
Teaching
5.9
37.9
116
242
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
36.9
37.0
47
14
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
36.9
35
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.9
36.5
189
672
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
383.7
36.5
36
*
A04AA01
ATC
ondansetron; systemic, rectal
19.8
36.3
55
31
N02AA05
ATC
oxycodone; systemic
5.0
34.5
124
309
JGB07
NOMESCO Finland
Laparoscopic partial proctectomy with total excision of mesorectum
+∞
32.7
31
*
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
94.0
32.2
35
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
332.7
31.2
31
*
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
+∞
30.5
29
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
30.5
29
*
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
110.0
29.0
31
*
116
Kela drug reimbursment
Prostate cancer
+∞
28.4
27
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
28.4
27
*
UJG02
NOMESCO Finland
Proctoscopy
13.2
27.1
48
40
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
79.8
27.1
30
*
WX402
NOMESCO Finland
General anaesthesia
4.3
26.4
108
300
A04AA55
ATC
palonosetron, combinations; systemic
+∞
26.3
25
*
8480/3-C19.9
ICD-O-3
Mucinous adenocarcinoma of rectosigmoid junction
+∞
25.2
24
*
JFB46
NOMESCO Finland
Resection of sigmoid colon
25.0
25.1
35
15
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
13.3
25.1
44
36
JG1CG
NOMESCO Finland
Extensive MRI of rectum
73.8
25.1
28
*
JFB54
NOMESCO Finland
Laparoscopic resection of sigmoid colon with partial proctectomy
136.8
24.8
26
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
13.4
24.0
42
34
TJF80
NOMESCO Finland
Ostomy education
35.3
23.6
30
9
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
23.1
22
*
WF002
NOMESCO Finland
Radical radiotherapy
125.8
22.8
24
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
6.1
22.3
63
115
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
22.0
21
*
115
Kela drug reimbursment
Breast cancer
+∞
22.0
21
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
22.0
21
*
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
120.3
21.8
23
*
Z93
ICD-10 Finland
Artificial opening status
218.7
20.7
21
*
JFF10
NOMESCO Finland
Loop enterostomy
114.8
20.7
22
*
JAH00
NOMESCO Finland
Laparotomy
11.0
20.5
39
38
Z93.3
ICD-10 Finland
Colostomy status
60.1
20.1
23
*
JN4CD
NOMESCO Finland
Very extensive body CT
10.0
20.0
40
43
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.5
20.0
44
56
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
+∞
19.9
19
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
19.9
19
*
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
207.9
19.7
20
*
JFB53
NOMESCO Finland
Resection of sigmoid colon with partial proctectomy
207.9
19.7
20
*
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
207.9
19.7
20
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.9
19.0
65
149
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.1
18.9
78
215
A04AD12
ATC
aprepitant; systemic
+∞
18.9
18
*
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
+∞
17.8
17
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
17.8
17
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
17.8
17
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
N02BE01
ATC
paracetamol; systemic, rectal
2.9
17.7
430
3421
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.0
17.2
39
52
PJA12
NOMESCO Finland
Sentinel node biopsy
175.6
16.6
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
16.6
133
592
ZX120
NOMESCO Finland
Intravenous
4.3
16.5
64
166
SPAT1125
SPAT
Stoma care and guidance
11.7
16.5
30
27
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
21.8
16.1
23
11
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
15.7
15
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
15.7
15
*
WX704
NOMESCO Finland
Intubation
4.4
15.6
58
144
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.9
15.0
50
111
B01AB04
ATC
dalteparin; parenteral
5.3
15.0
46
93
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
58.5
14.9
17
*
369
Kela drug reimbursment
Regorafenib
+∞
14.7
14
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
14.7
14
*
JGB01
NOMESCO Finland
Laparoscopic partial proctectomy and colorectal or coloanal anastomosis
154.3
14.5
15
*
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
43.8
14.2
17
*
ZXC96
NOMESCO Finland
Robot assisted procedure
20.8
13.9
20
10
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
8.0
13.9
31
41
D18
ICPC
Change in faeces/bowel movements
9.2
13.7
28
32
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
WX600
NOMESCO Finland
Single shot through catheter
35.1
13.6
17
5
L02AE02
ATC
leuprorelin; implant, parenteral
35.1
13.6
17
5
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
11.9
13.4
24
21
K56.7
ICD-10 Finland
Ileus, unspecified
9.4
13.4
27
30
JF2AB
NOMESCO Finland
Colongraphy with X-ray
29.2
13.0
17
6
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
8.6
12.7
27
33
L02BG04
ATC
letrozole; oral
33.0
12.6
16
5
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
5.2
12.6
39
80
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
12.5
12
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
12.5
12
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
12.5
12
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.5
12.5
32
52
A79
ICPC
Malignancy NOS
133.2
12.5
13
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
12.1
12.4
22
19
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.3
12.4
66
223
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.1
12.4
39
82
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
13.8
12.0
20
15
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
11.9
57
178
JFB00
NOMESCO Finland
Partial resection of small intestine
16.9
11.7
18
11
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.9
11.7
49
137
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
19.5
11.7
17
9
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
23.5
11.6
16
7
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
11.5
11
*
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
11.5
11
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
11.5
11
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
11.5
11
*
SPAT1262
SPAT
Handing over of treatment supplies
2.3
11.5
119
593
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
122.7
11.5
12
*
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.5
11.3
40
95
WX725
NOMESCO Finland
Noninvasive ventilation
4.5
10.9
38
89
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.5
10.9
25
35
JAH01
NOMESCO Finland
Laparoscopy
6.2
10.7
28
47
L03AA02
ATC
filgrastim; parenteral
61.3
10.7
12
*
E0000UV
ATC
NA
2.0
10.5
188
1178
Y77
ICPC
Malignant neoplasm prostate
112.3
10.5
11
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
10.4
10
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
10.4
10
*
176
Kela drug reimbursment
Regorafenib
+∞
10.4
10
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
10.4
10
*
JFB43
NOMESCO Finland
Left hemicolectomy
33.3
10.4
13
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
9.8
222
1505
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
9.7
68
275
6434
FHL
Anterior resection
56.1
9.7
11
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
56.1
9.7
11
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.6
9.6
20
24
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
101.9
9.4
10
*
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
101.9
9.4
10
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
9.4
9
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
9.4
9
*
L01XE21
ATC
[U] regorafenib; oral
+∞
9.4
9
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
9.4
9
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
9.4
9
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
9.4
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.4
9
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
9.4
9
*
L02BB03
ATC
bicalutamide; oral
+∞
9.4
9
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
9.4
9
*
WW500
NOMESCO Finland
Blood transfusion
6.6
9.4
23
36
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.2
9.2
34
85
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
24.5
8.9
12
5
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
20.4
8.5
12
6
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
8.5
92
464
WX400
NOMESCO Finland
Inhalation anesthesy
5.2
8.4
25
50
Z31.5
ICD-10 Finland
Genetic counselling
6.9
8.4
20
30
D16
ICPC
Rectal bleeding
6.9
8.4
20
30
JFF26
NOMESCO Finland
Sigmoidostomy
91.5
8.4
9
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.2
8.4
44
148
SPAT1153
SPAT
Removal of sutures
1.9
8.4
158
991
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
8.4
8
*
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
8.4
8
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
8.4
8
*
JFF24
NOMESCO Finland
Laparoscopic transversostomy
+∞
8.4
8
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
8.4
8
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
8.4
8
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
+∞
8.4
8
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
8.4
8
*
1XC07
NOMESCO Finland
NA
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.8
8.2
26
56
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
17.5
8.1
12
7
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
7.1
7.8
18
26
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
7.1
7.8
18
26
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.6
7.5
18
28
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
7.4
89
468
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
4.9
7.4
23
49
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
C18
ICD-10 Finland
Malignant neoplasm of colon
+∞
7.3
7
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
+∞
7.3
7
*
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
7.3
7
*
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
+∞
7.3
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.3
7
*
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
+∞
7.3
7
*
1541A
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]
+∞
7.3
7
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
16.0
7.3
11
7
WX720
NOMESCO Finland
Own respiration
4.3
7.2
25
60
D70.82
ICD-10 Finland
Drug-induced neutropenia
20.4
7.2
10
5
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
12.3
7.1
12
10
S18
ICPC
Laceration/cut
1.7
7.1
193
1349
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.8
7.0
45
173
Z98.8
ICD-10 Finland
Other specified postsurgical states
11.1
6.8
12
11
TJG20
NOMESCO Finland
Transanal irrigation
40.6
6.8
8
*
Z93.2
ICD-10 Finland
Ileostomy status
40.6
6.8
8
*
JFB30
NOMESCO Finland
Right hemicolectomy
17.0
6.8
10
6
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.0
6.7
17
29
HAB40
NOMESCO Finland
Wedge excision of mammary gland
12.5
6.6
11
9
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
6.4
78
411
D77
ICPC
Malignant digestive neopl other/NOS
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
JJB60
NOMESCO Finland
Other excsion of three or more segments of liver
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
1540A
ICD-9 Finland
Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectosigmoid junction[NEOPL MALIG JUNCT RECTOSIGM,INVASIIVINEN KARSINOOMA]
+∞
6.3
6
*
YL1CD
NOMESCO Finland
Very extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
6.3
6
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
6.3
6
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
6.3
6
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
6.3
6
*
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
733
422
57.91
307.65
9.5
1.4
ug/l
22.6
3.6
2.23
643
315
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
221
152
18.24
255.24
5.1
1.9
u/ml
353.8
92.6
0.57
204
119
(3022145) Colonoscopy Study observation
387
720
8.01
216.58
1.5
1.3
—
—
—
0
0
(4035726)
187
198
11.32
163.69
1.3
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
117
89
14.70
125.67
5.6
1.7
u/ml
51.5
60.6
0.13
102
79
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
725
3747
4.16
99.62
14.7
3.8
umol/l
11.3
12.4
2.37
706
3485
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
648
3304
3.60
86.26
6.4
3.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
234
614
4.64
83.33
2.5
1.8
g/l
0.2
0.2
1.19
226
549
(3024561) Albumin [Mass/volume] in Serum or Plasma
646
3381
3.45
80.45
10.2
3.6
g/l
33.6
35.2
9.38
628
3088
(3044640) Blood type and Crossmatch panel - Blood
451
2170
2.92
60.07
3.3
2.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
226
751
3.57
56.29
3.1
2.3
umol/l
7.9
9.7
0.64
210
653
(40768804) Tissue Pathology biopsy report
444
2223
2.75
53.38
2.8
1.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
595
3460
2.71
52.80
10.1
11.7
inr
1.2
1.4
5.04
185
978
(3002256) Pathology report gross observation
180
535
3.87
52.71
1.3
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
656
4013
2.75
52.42
17.6
6.1
e9/l
3.9
4.4
8.59
596
3443
(3023368) Bacteria identified in Blood by Culture
440
2262
2.65
49.28
4.8
4.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
444
2417
2.47
42.58
2.9
2.3
u/l
55.0
57.4
0.74
425
2206
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
344
1693
2.55
40.66
3.4
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
250
1054
2.81
40.28
2.1
2.5
%
19.1
22.7
4.09
205
883
(3004789) Transferrin [Mass/volume] in Serum or Plasma
261
1126
2.77
40.23
2.2
2.4
g/l
2.3
2.3
0.79
252
1031
(3022948) Iron [Moles/volume] in Serum or Plasma
276
1244
2.67
38.87
2.3
2.4
umol/l
11.6
12.7
1.78
265
1125
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
141
435
3.60
38.55
9.2
9.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
404
2224
2.34
36.48
6.6
2.6
u/l
36.0
34.7
0.23
391
2110
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
797
5858
2.60
36.34
16.4
5.3
u/l
90.4
76.8
7.77
773
5371
(3037121) Protein [Mass/volume] in Urine
102
274
4.02
33.95
7.4
2.5
g/l
0.2
0.3
0.14
87
90
(3012095) Magnesium [Moles/volume] in Serum or Plasma
249
1145
2.55
33.06
6.4
2.4
mmol/l
0.8
0.8
4.68
232
1051
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
589
3957
2.14
30.83
9.5
5.5
mmol/l
1.2
1.2
5.20
505
3324
(3013826) Glucose [Moles/volume] in Serum or Plasma
668
4735
2.17
30.09
6.5
4.4
mmol/l
7.0
6.9
0.24
654
4441
(3016502) Oxygen saturation in Arterial blood
202
880
2.61
29.72
8.6
6.8
%
96.4
95.0
1.59
194
849
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
216
974
2.54
29.58
8.5
6.6
kpa
5.2
5.1
0.90
207
933
(3027801) Oxygen [Partial pressure] in Arterial blood
216
974
2.54
29.58
8.5
6.6
kpa
14.3
11.4
9.85
207
932
(3002173) Hemoglobin [Mass/volume] in Arterial blood
189
804
2.65
29.14
9.1
7.2
g/l
115.8
121.3
3.52
180
779
(3015377) Calcium [Moles/volume] in Serum or Plasma
419
2530
2.11
28.41
7.5
2.0
mmol/l
2.3
2.3
0.70
393
2067
(3003396) Base excess in Arterial blood by calculation
213
973
2.50
28.27
8.5
6.6
mmol/l
0.4
1.3
2.78
170
758
(3014576) Chloride [Moles/volume] in Serum or Plasma
212
988
2.44
26.82
7.8
5.8
mmol/l
105.2
104.4
1.49
207
957
(3018572) Chloride [Moles/volume] in Blood
76
198
4.06
26.29
8.7
6.9
mmol/l
106.8
105.7
1.42
69
185
(3039000) Anion gap in Blood
76
198
4.06
26.29
8.7
6.9
mmol/l
11.3
11.2
0.13
69
185
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
527
3603
1.95
23.97
8.4
5.1
mmol/l
1.2
1.2
4.21
495
3160
(3003694) ABO and Rh group [Type] in Blood
308
1772
2.05
22.80
1.4
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
88
280
3.34
22.66
8.3
6.2
mmol/l
1.4
1.3
0.43
78
255
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
106
378
3.01
22.55
7.4
4.7
%
1.4
1.7
1.78
98
364
(3007930) Methemoglobin/Hemoglobin.total in Blood
104
368
3.03
22.42
7.4
4.8
%
0.9
0.9
0.02
96
354
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
273
1526
2.07
21.71
8.7
2.2
mmol/l
2.5
2.4
4.41
258
1303
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
345
2102
1.96
21.49
2.2
2.2
mg/l
3.5
2.9
1.89
314
1756
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
140
607
2.51
20.38
2.1
2.1
u/l
31.3
33.1
0.38
129
496
(3042936) Bacteria identified in Isolate by Culture
212
1104
2.16
20.14
1.8
2.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
127
548
2.50
18.62
1.5
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
133
593
2.43
18.15
7.3
4.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
363
2384
1.81
17.10
4.0
3.1
e6/l
61.2
94.5
0.40
303
1835
(3026008) Bacteria identified in Urine by Culture
372
2480
1.78
16.54
3.6
3.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
648
5141
1.70
14.66
5.4
4.5
e6/l
309.5
3326.1
—
10
85
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
72
263
2.87
14.62
2.8
2.7
u/ml
0.3
0.4
0.30
45
157
(3018418) pH of Serum or Plasma
341
2281
1.74
14.61
5.5
3.2
ph
7.4
7.4
0.22
77
373
(3008152) Bicarbonate [Moles/volume] in Arterial blood
122
576
2.27
14.52
10.0
6.9
mmol/l
24.3
24.5
0.26
115
540
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
406
2859
1.69
14.36
4.0
3.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
142
723
2.12
13.99
6.5
6.1
mmol/l
10.7
11.1
0.19
134
677
(3000850) Epithelial cells [#/volume] in Urine
264
1677
1.77
13.36
3.0
2.4
e6/l
7.7
5.0
0.87
238
1456
(3025941) Bacteria identified in Stool by Culture
83
342
2.55
13.34
1.4
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
321
2167
1.70
13.02
3.9
3.0
e6/l
0.5
0.4
0.26
256
1642
(3018095) Leukocytes [#/volume] in Urine
389
2763
1.66
12.99
4.6
3.5
e6/l
216.6
106.7
0.77
312
1970
(3000991) Gas panel - Venous blood
131
665
2.11
12.98
7.5
6.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
457
3385
1.63
12.88
4.7
5.5
%
2.6
3.0
2.60
433
3107
(3001122) Ferritin [Mass/volume] in Serum or Plasma
422
3069
1.64
12.78
2.9
2.7
ug/l
128.6
142.8
0.76
404
2769
(3002030) Lymphocytes/100 leukocytes in Blood
462
3456
1.61
12.34
5.1
5.6
%
23.4
26.4
7.09
431
3171
(3019069) Monocytes/100 leukocytes in Blood
456
3402
1.61
12.31
5.2
5.7
%
9.1
8.9
0.46
430
3135
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
65
248
2.73
12.18
1.4
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
350
2454
1.65
12.11
4.5
5.4
—
—
—
0
0
(3026782) Osmolality of Urine
246
1579
1.73
11.83
3.4
2.6
mosm/kgh2o
543.8
560.1
0.55
219
1308
(3022096) Basophils/100 leukocytes in Blood
440
3285
1.59
11.65
5.0
5.4
%
0.6
0.7
4.48
415
3022
(3018010) Neutrophils/100 leukocytes in Blood
455
3426
1.59
11.60
5.1
5.4
%
60.3
58.3
2.43
430
3162
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
864
7625
1.83
11.37
27.7
14.1
mg/l
37.4
25.1
11.47
805
6010
(3003458) Phosphate [Moles/volume] in Serum or Plasma
176
1046
1.82
10.94
5.3
4.8
mmol/l
1.1
1.0
1.49
165
949
(36304419) Bacteria [Presence] in Urine
301
2082
1.63
10.76
3.7
3.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
55
208
2.74
10.50
1.6
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
114
597
2.02
10.34
4.7
3.0
mmol/l
1.2
1.2
0.18
108
492
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
94
3.59
10.11
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
249
1680
1.64
9.69
12.6
4.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
75
343
2.28
9.60
2.1
1.8
ug/l
2.1
1.9
0.09
69
297
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
212
1378
1.68
9.53
1.8
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
144
839
1.83
9.49
4.8
3.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
466
3638
1.51
9.48
4.7
5.2
e9/l
0.0
0.0
4.24
404
3109
(3019198) Lymphocytes [#/volume] in Blood
471
3691
1.51
9.38
4.7
5.3
e9/l
1.6
1.8
2.28
405
3207
(40768441) Liver Pathology biopsy report
17
30
5.75
9.30
1.1
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
462
3615
1.50
9.22
4.6
5.2
e9/l
0.6
0.6
0.04
397
3085
(3013115) Eosinophils [#/volume] in Blood
476
3751
1.50
9.16
4.8
5.4
e9/l
0.2
0.2
2.24
418
3249
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
32
5.38
8.70
1.1
1.3
—
—
—
0
0
(4281824)
18
36
5.07
8.64
1.2
1.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
137
813
1.79
8.47
3.6
2.8
u/l
273.3
244.2
1.06
132
751
(3018677) aPTT in Platelet poor plasma by Coagulation assay
192
1255
1.65
8.36
2.1
1.8
s
29.6
30.1
0.50
186
1209
(3037467) Urinalysis macro (dipstick) panel - Urine
637
5407
1.47
7.93
5.8
4.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
185
1239
1.60
7.24
3.8
2.9
e6/l
1.8
2.0
0.16
106
675
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
543
4532
1.42
7.02
3.8
3.0
u/l
69.4
50.2
3.02
511
4113
(3012501) Base excess in Blood by calculation
42
171
2.52
7.00
5.2
4.6
mmol/l
2.3
2.8
0.52
32
113
(3044889) 12 lead EKG panel
657
5677
1.44
6.97
4.7
4.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
25
77
3.30
6.86
1.6
2.0
—
327.8
—
0
8
(3023183) Ammonium ion [Moles/volume] in Plasma
41
167
2.52
6.83
2.8
2.5
umol/l
30.8
34.9
0.52
36
145
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
83
457
1.89
6.53
2.4
2.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
104
619
1.76
6.36
5.5
4.0
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
136
880
1.63
6.09
2.9
3.1
ng/l
246.9
256.5
0.08
121
820
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
145
970
1.58
5.65
1.8
1.8
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
121
776
1.63
5.62
2.1
2.3
e9/l
69.4
68.0
0.10
84
606
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
16
42
3.85
5.55
2.2
1.3
ug/l
21.6
14.9
0.50
16
42
(3019550) Sodium [Moles/volume] in Serum or Plasma
882
8186
1.54
5.54
34.0
17.2
mmol/l
139.3
139.8
5.95
863
7940
(40760892) CBC W Ordered Manual Differential panel - Blood
201
1451
1.48
5.50
4.4
4.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
20
62
3.27
5.47
1.3
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
883
8206
1.54
5.42
34.1
17.3
mmol/l
4.0
4.0
3.27
862
7947
(3002385) Erythrocyte distribution width [Ratio]
688
6114
1.38
5.41
37.3
16.8
%
14.6
13.8
25.60
676
5939
(3035350) Ketones [Presence] in Urine by Test strip
455
3805
1.35
5.24
4.6
3.7
estimate
0.0
0.0
0.00
106
660
(3027945) Reticulocytes/100 erythrocytes in Blood
151
1037
1.53
5.24
2.2
2.0
%
1.8
1.8
0.00
141
900
(3013707) Erythrocyte sedimentation rate by Westergren method
652
5763
1.36
5.18
3.7
4.2
mm/h
16.5
13.1
4.61
598
5250
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
142
966
1.55
5.14
1.8
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
37
165
2.29
5.12
4.1
3.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
92
565
1.69
5.05
1.3
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
394
3238
1.35
5.04
17.1
8.9
e9/l
0.0
0.0
0.22
334
2633
(3020891) Body temperature
64
355
1.86
4.97
5.5
4.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
270
2094
1.39
4.95
5.1
4.0
estimate
0.0
0.0
0.50
97
630
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
37
168
2.25
4.93
2.5
2.3
g/l
3.3
3.5
0.39
37
156
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
100
2.64
4.92
3.6
4.8
iu/ml
28729.4
478.8
—
5
12
(3017181) Myelocytes/100 leukocytes in Blood
92
570
1.67
4.89
3.2
3.7
%
1.2
0.8
0.74
37
134
(3041096) Erythrocytes [Presence] in Urine by Automated
255
1966
1.39
4.83
4.9
3.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
68
389
1.80
4.79
1.7
1.6
g/l
1.8
1.5
1.11
59
333
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
183
1336
1.45
4.69
3.6
2.7
e6/l
0.9
1.2
0.97
103
771
(3021601) Nitrite [Presence] in Urine by Test strip
450
3804
1.33
4.65
6.1
5.0
estimate
0.0
0.0
0.00
108
660
(3002032) Base excess in Venous blood by calculation
120
809
1.55
4.53
3.3
3.2
mmol/l
1.9
2.1
0.22
96
643
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
230
1764
1.39
4.46
3.5
4.0
ng/l
127.0
449.6
3.29
189
1495
(3009261) Glucose [Presence] in Urine by Test strip
452
3859
1.31
4.22
4.7
3.7
estimate
0.0
0.0
0.50
107
646
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
13
6.97
4.17
1.2
2.9
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
28
126
2.26
3.86
3.1
2.8
%
56.9
60.3
0.65
28
126
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
701
7582
0.76
3.84
4.5
4.8
mmol/l
1.4
1.4
0.46
642
6847
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
400
3392
1.29
3.83
3.9
4.1
ng/l
38.0
71.3
1.32
316
2558
(3048689) Calprotectin [Mass/mass] in Stool
107
731
1.52
3.81
1.6
2.1
ug/g
199.2
151.9
0.63
88
571
(3002179) Metamyelocytes/100 leukocytes in Blood
81
520
1.61
3.79
2.3
3.7
%
0.7
0.6
0.05
23
100
(3021440) Promyelocytes/100 leukocytes in Blood
84
545
1.59
3.76
2.8
3.8
%
0.3
0.1
0.93
32
121
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
351
2936
1.30
3.70
5.2
4.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
732
7859
0.76
3.68
5.1
5.5
mmol/l
2.6
2.6
0.21
668
7112
(3045142) Bone marrow Pathology biopsy report
16
56
2.89
3.64
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
27
123
2.23
3.63
2.8
2.6
e9/l
4.0
4.6
0.74
27
123
(3017143) Hepatitis C virus Ab [Presence] in Serum
83
542
1.58
3.63
1.3
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
50
285
1.79
3.62
2.4
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
123
878
1.46
3.54
1.6
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
39
207
1.92
3.53
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
725
6673
1.29
3.45
29.9
15.6
%
37.2
39.3
5.60
433
4162
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
773
7182
1.31
3.38
29.1
13.1
ml/min/173m2
75.2
74.1
0.77
665
5776
(40761511) CBC panel - Blood by Automated count
838
7885
1.34
3.27
28.9
13.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
889
8442
1.39
3.26
43.6
20.6
e9/l
247.6
240.2
2.24
861
8135
(3024731) MCV [Entitic volume]
889
8443
1.39
3.25
43.4
20.6
fl
91.2
91.7
2.22
871
8252
(3025159) Blasts/100 leukocytes in Blood
78
516
1.55
3.24
2.8
3.9
%
0.0
0.9
0.55
23
105
(3035941) MCH [Entitic mass]
889
8444
1.39
3.24
43.3
20.5
pg
30.1
30.5
7.33
871
8253
(3026361) Erythrocytes [#/volume] in Blood
889
8445
1.39
3.23
43.5
20.6
e12/l
4.3
4.5
24.37
861
8100
(3010813) Leukocytes [#/volume] in Blood
889
8446
1.39
3.22
43.6
20.7
e9/l
6.9
6.8
0.23
862
8106
(3042631) Mycobacterium sp identified in Specimen
22
97
2.30
3.21
1.7
2.8
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
889
8447
1.39
3.20
43.8
20.8
g/l
127.2
135.5
44.36
871
8254
(3042111) Morphology [Interpretation] in Bone marrow Narrative
25
117
2.17
3.18
1.5
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
30
151
2.02
3.17
1.3
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
38
208
1.86
3.16
1.1
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
716
7662
0.78
3.12
4.6
4.8
mmol/l
4.5
4.5
0.01
662
6976
(3043410) Blood group antigens tested for on Red Blood Cells
9
20
4.53
3.11
1.4
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
38
211
1.83
3.04
1.1
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
87
2.32
3.02
1.4
1.4
—
—
—
0
0
(3013512) EKG study
304
2553
1.27
3.01
4.0
4.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
12
40
3.02
2.98
1.1
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
12
40
3.02
2.98
1.1
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
31
162
1.94
2.97
3.3
2.4
%
14.8
16.3
0.87
11
85
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
74
1076
0.66
2.94
4.5
5.0
%
32.4
32.9
0.17
54
690
(3021879) Hepatitis B virus core Ab [Presence] in Serum
53
328
1.65
2.92
1.2
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
861
8169
1.33
2.90
19.4
9.3
u/l
24.3
25.0
0.73
840
7768
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
52
2.72
2.89
1.0
1.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
36
3.08
2.81
1.2
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
33
181
1.85
2.76
1.5
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
684
7323
0.80
2.74
4.2
4.3
mmol/l
1.3
1.3
0.31
631
6545
(3033705) Calcium.ionized [Moles/volume] in Venous blood
23
111
2.10
2.74
3.5
2.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
175
1393
1.31
2.60
1.2
1.2
u/ml
1.3
1.7
0.35
41
371
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
699
7452
0.81
2.60
6.5
6.6
mmol/mol
41.0
41.0
0.05
642
6811
(1761482) Bacteria [#/volume] in Urine by Culture
41
245
1.70
2.60
4.2
4.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
15
4.69
2.60
1.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
20
4.02
2.57
6.0
2.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
53
340
1.59
2.56
1.7
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
44
2.75
2.55
1.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
44
2.75
2.55
1.0
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
23
115
2.02
2.52
3.5
2.3
mmol/l
4.1
4.1
0.19
23
115
(3035285) Chloride [Moles/volume] in Venous blood
23
115
2.02
2.52
3.5
2.3
mmol/l
108.0
105.2
1.61
23
115
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
27
145
1.89
2.43
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
191
0.36
2.42
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
114
863
1.36
2.39
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
104
2.04
2.37
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
71
2.27
2.35
3.2
2.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
35
2.88
2.31
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
35
2.88
2.31
1.2
1.0
—
—
—
0
0
(3036489) Thrombin time
37
223
1.68
2.30
1.8
1.9
s
23.0
21.3
0.49
32
200
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
177
2153
0.79
2.26
1.6
1.6
mmol/l
1.4
1.3
0.88
145
1769
(3033799) Differential panel - Peritoneal fluid
7
18
3.91
2.25
1.4
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
280
1.60
2.23
1.2
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
164
1322
1.29
2.23
27.9
29.7
inr
1.6
1.5
0.59
38
191
(4010399)
39
610
0.63
2.21
1.2
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
74
528
1.43
2.21
1.7
1.6
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
9
213
0.42
2.20
1.2
1.3
mg/l
643.4
508.2
—
9
202
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
17
80
2.14
2.19
1.2
1.5
pmol/l
357.4
62.8
0.57
17
80
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
101
2.00
2.16
1.1
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
357
3149
1.20
2.12
2.3
2.2
nmol/l
75.5
78.5
1.09
329
2704
(3051611) Lipemic interference index of Serum or Plasma
15
68
2.22
2.11
6.7
2.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
12
49
2.47
2.11
1.4
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
48
318
1.53
2.07
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
154
1.77
2.05
1.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
32
2.83
2.00
8.0
2.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
94
1222
0.75
1.99
1.3
1.3
iu/ml
96.8
39.9
1.08
34
385
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
8
188
0.42
1.94
1.3
1.2
mmol/l
4.1
4.0
—
8
177
(3045716) Anion gap in Serum or Plasma
11
45
2.46
1.93
3.0
1.6
mmol/l
8.0
11.0
—
6
37
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
143
1.77
1.90
1.6
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
276
1.54
1.90
1.0
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
90
1168
0.75
1.88
1.2
1.3
u/ml
19.3
14.7
0.18
27
436
(3034770) Mitochondria Ab [Titer] in Serum
32
197
1.64
1.88
1.1
1.1
—
602.0
—
0
5
(40768793) Breast Pathology biopsy report
11
46
2.41
1.85
1.0
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
147
1198
1.26
1.84
1.5
1.3
g/l
2.8
2.8
0.01
87
686
(4034850)
16
299
0.53
1.80
16.3
11.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
103
1.86
1.72
1.3
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
85
651
1.33
1.71
3.0
3.5
ng/l
89.4
92.4
0.16
78
558
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
14
68
2.07
1.70
1.0
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
161
0.43
1.68
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
25
2.81
1.65
2.1
2.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
34
222
1.55
1.61
3.1
3.4
mmol/l
22.5
25.0
1.53
29
194
(3038515) Glucose [Moles/volume] in Venous blood
31
198
1.58
1.61
4.5
2.9
mmol/l
7.7
7.6
0.10
31
192
(21494890) Protein electrophoresis panel - 24 hour Urine
14
70
2.01
1.59
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
104
829
1.28
1.58
5.5
3.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
12
234
0.51
1.57
1.6
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
26
161
1.63
1.53
3.2
2.9
—
—
—
0
0
(4133840)
5
15
3.34
1.52
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
43
0.00
1.52
0.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
21
2.87
1.50
1.5
2.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
72
1.96
1.49
1.0
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
57
421
1.37
1.47
4.9
3.2
%
48.5
47.4
0.13
57
413
(40760888) Immunoglobulin light chains.free panel - Serum
30
195
1.55
1.47
2.6
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
87
1.85
1.46
1.4
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
87
1.85
1.46
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
22
2.74
1.43
1.0
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
124
1025
1.24
1.41
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
20
119
1.69
1.38
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
496
1.33
1.38
1.4
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
16
89
1.81
1.37
1.3
1.3
u/ml
54.2
110.6
—
5
10
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
85
675
1.28
1.36
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
173
2002
0.84
1.35
3.2
2.8
ug/l
0.9
0.8
0.46
130
1387
(3045424) Erythrocytes [Presence] in Urine
17
98
1.75
1.31
1.7
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
201
1.51
1.31
1.8
1.5
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
24
2.51
1.30
1.5
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
43
2.10
1.30
1.2
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.3
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.3
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
206
2339
0.85
1.29
3.4
3.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
319
2890
1.15
1.28
2.6
3.0
ng/l
1522.2
1685.9
0.37
278
2467
(1002224) Polysomnography panel
13
230
0.56
1.28
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
38
269
1.43
1.27
2.7
1.5
mg/l
33.5
56.4
0.56
33
218
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
44
2.05
1.27
3.9
2.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
38
270
1.42
1.25
2.7
1.5
mg/l
53.9
47.1
0.28
33
219
(21494755) Public health laboratory ask at order entry panel
22
338
0.64
1.25
1.2
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
64
496
1.31
1.24
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
100
1.71
1.24
1.1
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
745
7729
0.87
1.22
4.9
5.0
mmol/l
6.1
6.1
0.34
676
6901
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
19
2.64
1.21
1.2
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
16
93
1.73
1.21
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
188
0.53
1.21
1.2
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
275
0.61
1.21
1.6
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
272
0.62
1.16
1.3
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
20
2.51
1.15
1.4
1.9
—
—
—
0
0
(4015189)
0
36
0.00
1.14
0.0
2.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
36
0.00
1.14
0.0
6.4
—
54.9
—
0
9
(3036782) Glucose [Moles/volume] in Pleural fluid
12
65
1.86
1.13
1.2
1.3
mmol/l
6.0
7.6
1.04
12
60
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
95
1139
0.82
1.10
12.8
7.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
104
1.65
1.09
1.2
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
8
41
1.96
1.09
1.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
105
1.63
1.06
1.3
1.3
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
5
22
2.28
1.03
1.2
1.9
nmol/l
16.8
13.0
—
5
14
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
47
1.92
1.02
1.1
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
27
188
1.45
1.02
2.8
2.1
g/l
119.2
133.0
2.34
22
138
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.01
1.7
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.01
1.7
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
53
1.90
1.01
1.7
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
239
2160
1.14
0.99
1.7
1.6
nmol/l
19.3
20.5
0.69
215
1804
(3029075) Extractable nuclear Ab panel - Serum
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
654
6271
1.12
0.97
39.6
18.7
g/l
329.7
332.2
8.43
645
6208
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
398
0.72
0.96
2.3
1.9
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
19
125
1.53
0.94
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
21
302
0.69
0.91
1.2
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
639
1.22
0.90
5.4
2.4
ml/min/173m2
58.2
62.4
0.54
35
259
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
30
2.01
0.87
1.5
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
96
1.57
0.84
1.1
1.2
nmol/l
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
31
1.94
0.84
2.7
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
31
1.94
0.84
1.3
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
112
0.53
0.83
2.2
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
8
46
1.74
0.82
1.1
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
232
1.35
0.82
1.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
294
0.71
0.81
1.2
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
47
1.71
0.80
1.0
1.3
nmol/l
160.3
146.6
—
8
47
(3045414) Leukocytes [Presence] in Urine
41
321
1.29
0.80
1.7
1.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
24
0.00
0.79
0.0
7.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
124
0.56
0.78
1.4
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
24
2.09
0.74
1.4
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
24
2.09
0.74
1.4
2.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
24
2.09
0.74
1.4
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
116
1.47
0.74
1.3
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
8
136
0.59
0.73
3.9
2.0
pmol/l
209.4
213.2
—
8
126
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
15
100
1.51
0.73
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
56
462
1.22
0.73
4.9
3.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
25
2.00
0.72
1.2
1.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
5
25
2.00
0.72
1.6
1.3
%
28.6
20.2
—
5
17
(44806420)
7
39
1.80
0.72
2.3
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
117
1.46
0.72
4.2
3.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
16
109
1.48
0.71
1.1
1.2
nmol/l
—
0.6
—
0
8
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
5
26
1.93
0.70
1.0
1.1
—
1.0
—
0
9
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
61
510
1.21
0.70
3.6
3.5
mmol/l
2.1
1.9
0.19
40
376
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
390
3689
1.09
0.69
2.3
2.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
27
1.86
0.68
1.4
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
12
178
0.67
0.65
2.2
1.8
nmol/l
38.2
44.1
0.53
12
167
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
95
1.48
0.64
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
129
1.40
0.63
1.2
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
12
79
1.53
0.62
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
30
1.67
0.61
3.2
4.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
88
1.48
0.60
1.2
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
20
0.00
0.60
0.0
8.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
16
114
1.41
0.59
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
62
530
1.18
0.59
3.6
3.6
ph
7.4
7.4
—
8
62
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
23
0.00
0.58
0.0
1.2
—
9.5
—
0
23
(44790047)
11
73
1.51
0.56
1.9
1.3
—
—
—
0
0
(44806118)
11
73
1.51
0.56
1.9
1.3
—
—
—
0
0
(44790049)
11
73
1.51
0.56
1.9
1.3
—
—
—
0
0
(44790048)
11
73
1.51
0.56
1.9
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
203
1883
1.10
0.56
3.9
3.6
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
37
1.63
0.55
1.5
2.0
nmol/l
14.7
17.4
—
6
28
(3035880) pH of Pleural fluid
6
37
1.63
0.55
1.0
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
37
1.63
0.55
2.3
2.2
u/ml
1526.2
1304.2
—
6
37
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
63
543
1.17
0.55
3.6
3.6
kpa
5.0
5.2
0.92
58
498
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
38
1.58
0.54
1.2
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
101
903
1.13
0.54
2.0
2.6
ug/l
7.2
7.3
0.02
86
781
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
9
61
1.48
0.53
1.2
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
11
74
1.49
0.53
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
91
1.43
0.53
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
168
1553
1.10
0.50
1.7
1.6
mg/l
1.8
1.3
1.07
133
1194
(3000570) Elastase.pancreatic [Mass/mass] in Stool
24
189
1.28
0.50
1.3
1.4
ug/g
215.5
295.2
1.60
18
112
(3000492) Spirometry study
51
593
0.85
0.49
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
84
1.43
0.49
1.2
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
15
201
0.74
0.49
1.1
1.2
—
36.3
—
0
10
(3017569) Oxygen content in Arterial blood
7
45
1.56
0.49
1.7
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
265
2802
0.93
0.49
3.7
3.2
mg/l
75.8
188.4
1.34
189
1778
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
46
1.53
0.48
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
209
1957
1.09
0.47
1.7
1.7
pmol/l
413.9
15716518.0
1.26
176
1578
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
85
1.42
0.47
1.2
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
48
1.46
0.47
1.9
2.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
384
3682
1.07
0.46
2.2
2.1
pmol/l
86.0
93.6
3.06
247
1894
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
156
1.29
0.45
1.1
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
86
1.40
0.44
1.2
1.2
—
—
—
0
0
(4024509)
10
69
1.45
0.44
1.8
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
41
349
1.18
0.44
1.8
1.7
—
20.5
—
0
8
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
557
5726
0.94
0.43
3.7
3.7
pmol/l
14.9
15.0
0.34
505
5087
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
692
7066
0.94
0.43
4.5
4.5
mu/l
2.1
2.2
0.14
631
6307
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
67
752
0.88
0.42
1.5
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
72
804
0.89
0.42
1.2
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
8
58
1.38
0.41
1.0
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
55
483
1.15
0.41
1.2
1.3
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
126.3
—
0
16
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
79
1.40
0.41
1.3
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
17
0.00
0.40
0.0
1.1
—
31.3
—
0
12
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
34
1.47
0.40
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
88
1.37
0.40
1.2
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
88
1.37
0.40
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
269
1.20
0.40
1.9
3.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
18
0.00
0.40
0.0
4.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
61
1.31
0.39
1.3
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
1.0
1.3
promille
1.3
1.0
—
8
51
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
344
1.17
0.39
2.7
1.4
g/l
7.6
7.5
0.13
30
249
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
40
344
1.17
0.39
2.7
1.4
—
—
—
0
0
(4094501)
18
226
0.79
0.39
1.1
1.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
19
0.00
0.39
0.0
7.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
19
0.00
0.39
0.0
2.2
—
2.9
—
0
7
(3026493) Urate [Moles/volume] in Serum or Plasma
204
2158
0.93
0.39
3.0
2.5
umol/l
2639.5
7952.6
1.39
181
1814
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
151
1.26
0.38
1.2
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
261
2737
0.94
0.38
2.0
2.2
u/l
248.4
236.5
0.06
247
2547
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
21
258
0.81
0.38
2.9
2.3
ug/min
260.8
83.5
0.49
15
158
(3011412) CD3 cells [#/volume] in Blood
5
36
1.39
0.38
1.4
1.6
e9/l
1.2
1.0
—
5
19
(4306422)
10
72
1.39
0.37
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
9
70
1.29
0.36
1.1
1.1
%
115.3
118.0
—
9
64
(3039443) Prostate specific Ag panel - Serum or Plasma
11
146
0.75
0.36
1.7
1.7
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
5
79
0.63
0.35
1.0
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
6
43
1.40
0.35
1.0
1.6
u/field
5.0
3.7
—
6
33
(3037756) Immunofixation for Serum or Plasma
20
163
1.23
0.34
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
154
0.78
0.32
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
13
101
1.29
0.31
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
53
1.32
0.31
1.6
1.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
53
1.32
0.31
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
53
1.32
0.31
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
53
1.32
0.31
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
53
1.32
0.31
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
53
1.32
0.31
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
53
1.32
0.31
1.4
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
374
3626
1.05
0.30
5.0
4.0
ug/l
3.9
2.1
0.97
332
3223
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
39
344
1.14
0.30
2.7
1.4
g/l
4.0
3.9
0.26
28
243
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
106
0.75
0.29
1.1
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
176
1.20
0.29
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
189
1802
1.06
0.28
4.7
4.0
kg/l
1.0
1.0
0.64
33
282
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
317
1.14
0.28
2.8
1.4
g/l
3.3
3.1
0.38
28
246
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
26
223
1.17
0.28
1.2
1.2
—
7.2
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
20
236
0.84
0.27
1.3
1.8
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
5
75
0.67
0.26
1.0
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
74
1.22
0.25
1.2
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
13
105
1.24
0.25
1.4
1.4
%
60.3
68.1
—
8
69
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
76
1.19
0.24
1.6
1.2
nmol/l
1.5
1.6
—
9
64
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
81
0.74
0.24
1.5
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
190
0.84
0.23
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
190
0.84
0.23
1.1
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
39
1.28
0.23
2.4
2.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
42
1.19
0.21
1.6
1.4
g/l
0.8
0.9
—
5
42
(3044009) aPTT.lupus sensitive (LA screen)
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
22.6
—
0
11
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
16.1
—
0
5
(3019174) dRVVT (LA screen)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
57.6
—
0
12
(3016330) Potassium [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
3.4
—
7.5
—
0
13
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
25
221
1.13
0.20
6.0
3.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
73
685
1.07
0.19
3.5
1.6
g/l
63.3
66.9
2.94
66
615
(3017732) Neutrophils [#/volume] in Blood
53
491
1.08
0.19
3.7
3.0
e9/l
4.3
4.2
0.02
47
350
(3009508) Creatinine [Moles/volume] in Urine
278
2855
0.96
0.19
3.7
3.1
mmol/l
7.0
7.5
1.58
243
2379
(3032773) Endomysium IgG Ab [Titer] in Serum
6
52
1.15
0.19
1.3
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
192
1857
1.04
0.18
1.9
1.8
nmol/l
1227.7
1170.3
0.33
157
1391
(3003740) Influenza virus B Ag [Presence] in Specimen
7
58
1.21
0.18
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
121
0.82
0.18
2.7
2.7
—
—
—
0
0
(4062490)
7
60
1.17
0.18
1.1
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
31
281
1.11
0.17
3.1
1.4
g/l
1.1
0.5
0.59
26
242
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
14
163
0.86
0.17
1.1
1.2
—
8.3
—
0
12
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
62
1.13
0.17
2.0
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
69
0.72
0.17
1.8
3.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
194
0.87
0.16
1.6
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
8
68
1.18
0.16
1.9
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
78
0.77
0.15
1.0
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
78
0.77
0.15
1.0
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
79
0.76
0.15
1.0
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
89
932
0.95
0.15
1.2
1.3
titre
566.0
570.8
0.01
20
218
(3022313) Gas panel - Capillary blood
43
400
1.08
0.15
3.3
3.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
11
93
1.18
0.14
1.1
1.2
—
75.1
—
0
5
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
97
0.82
0.13
1.4
1.9
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
158
0.88
0.12
1.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
96
1.15
0.10
1.9
2.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.4
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.4
1.1
—
—
—
0
0
(4211845)
5
48
1.04
0.09
3.2
2.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
44
462
0.95
0.09
2.1
2.2
nmol/l
10.3
15.0
2.54
37
401
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
134
0.89
0.08
1.2
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
64
0.78
0.08
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
52
541
0.96
0.08
3.2
3.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
127
1.10
0.08
1.1
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
27
254
1.06
0.08
1.1
1.1
titre
—
219.0
—
0
9
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
75
0.80
0.07
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
75
1.07
0.07
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
8
76
1.05
0.07
1.3
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
87
1.03
0.07
1.0
1.1
—
21.5
—
0
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
94
0.85
0.06
3.1
3.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
105
0.86
0.06
2.6
1.7
mu/l
378.0
266.0
—
9
93
(40768443) Skin Pathology biopsy report
26
274
0.95
0.06
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
75
731
1.03
0.06
3.8
3.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
65
667
0.97
0.05
1.5
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
294
2965
0.99
0.05
4.5
4.0
mg/mmol
13.1
8.0
1.31
201
1880
(3014051) Protein [Presence] in Urine by Test strip
20
189
1.06
0.04
1.6
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
25
239
1.05
0.04
1.4
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
61
598
1.02
0.03
3.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
293
2945
0.99
0.02
4.6
3.9
%
22.0
24.3
1.92
159
1446
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
379
0.98
0.02
1.2
1.2
iu/ml
71.7
126.1
0.51
11
159
(3044941) Cell count panel - Synovial fluid
15
143
1.05
0.01
1.5
1.4
—
—
—
0
0
(4146454)
11
116
0.95
0.00
1.5
2.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
16
163
0.98
0.00
1.3
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
18
181
0.99
0.00
1.0
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
68
677
1.00
0.00
1.7
1.7
%
1.5
1.6
0.35
54
569
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
88
0.91
0.00
1.1
1.2
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
1.5
—
0
5
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
14.9
—
0
7
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
9
0.00
0.00
0.0
5.2
—
6.4
—
0
9
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
6
62
0.97
0.00
1.2
1.2
g/l
1.8
2.6
—
6
46
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
76
0.92
0.00
1.0
1.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.4
—
102.6
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
6
64
0.94
0.00
3.0
13.7
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
6
62
0.97
0.00
1.2
1.2
g/l
0.2
0.4
—
6
45
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
6
62
0.97
0.00
1.2
1.2
g/l
5.8
7.0
—
6
46
(3025315) Body weight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
6
64
0.94
0.00
1.0
1.2
mmol/l
43.9
36.0
—
6
57
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
70
1.00
0.00
1.1
1.9
%
9.7
10.4
—
7
70
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
13.1
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_RECTOSIGMOID_JUNCTION_EXALLC – Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).